Researchers at the University of Alabama, Birmingham Comprehensive Cancer Center received a $5.1 million support grant from the NIH this year. The abstract for the grant on NIH RePORTER says of the Comprehensive Cancer Center:
“The UAB Comprehensive Cancer Center is currently in its 39th year of continuous NCI CCSG funding. The Cancer Center has a well-established track record of translational research with a major emphasis on investigator-initiated early phase 1 and II trials, many of which emanate from Cancer Center scientific discoveries. In addition, the Center has major strengths in the area of cancer health disparity research. Current funding levels are $106.1M total direct, $32.0M NCI, $48.2M other NIH, $8.7M peer-reviewed, and $17.1M non-peer reviewed. There are 244 members representing 10 schools and 33 departments. The Cancer Center's research enterprise is organized around seven programs, including three basic science programs - Tumor Immunology, Cancer Cell Biology, and Virology; two translational/clinical programs - Experimental Therapeutics and Neuro-Oncology; and two prevention and control programs - Cancer Chemoprevention and Cancer Control and Population Sciences. The Center's research enterprise is supported by 15 shared facilities that support and enhance our basic, clinical, translational, and prevention and control research by providing research technology, advanced genomics, biostatistics/bioinformatics, tissue procurement, human and animal imaging, and recruitment and retention of trial participants.”
According to the University of Alabama, Birmingham website, the Comprehensive Cancer Center will also be debuting and reopening its Waller Tumor Institute. The $30 million renovation project began in 2010 and it is said that the institute will foster collaborative work and science research breakthroughs.
Birmingham BioResearch Product Faire™ Event 2012
In addition to this $5.1 million NIH grant for the University of Alabama, Birmingham’s Comprehensive Cancer Center, the university receives a great deal of additional NIH and NSF research funding. In 2012, the NIH awarded the University of Alabama at Birmingham $207.4 million. For a full list of schools receiving funding from the NIH at the University of Alabama at Birmingham, please visit the NIH website.
Lab suppliers interested in marketing their life science products and working to sell lab equipment at University of Alabama life science marketing events may also be interested to know that the NSF awarded the University of Alabama, Birmingham $6.1 million in 2012. For more NSF funding statistics on the University of Alabama, Birmingham, please visit the NSF website.
If you are a lab supplier interested in marketing your life science products and working to sell lab equipment, Biotechnology Calendar, Inc. invites you to attend our annual Birmingham BioResearch Product Faire™ Event on November 14th, 2013. Last year, the Birmingham BioResearch Product Faire™ Event attracted 336 attendees. Sixty-four of these attendees were purchasing agents, professors and post docs, and 62 were lab managers. The visitors came from 33 different research buildings and 45 departments across campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that organizes life science marketing events at top research universities across the country. If you’re interested in marketing your life science products and working to sell lab equipment at life science marketing events closer to home, we encourage you to view our 2013 calendar of events. For more information on the Birmingham BioResearch Product Faire™ Event, or to view more detailed funding statistics on the University of Alabama at Birmingham, click on the button below.